Retrospective diagnostic co-factors among Covid-19 cases sourced from Medicare, 1999-2021: an all-cause mortality review

Author:

Williams Nick1

Affiliation:

1. United States National Library of Medicine

Abstract

Abstract Introduction: SARS-CoV-2 infections co-occurred with other diverse pre-existing clinical conditions in mortality cases. We use encounter level health data to evaluate the impact of non-Covid-19 diagnostic events on all-cause mortality observed among Covid-19 positive cases billing Medicare. We further investigate prior diagnostic codes which occur in pre-pandemic study years among cases presenting to Medicare clinically with Covid-19 and cases with Covid-19 who experience all-cause mortality to inform patient population management. Methods: We aggregated encounter level records sourced from all Medicare beneficiaries from 1999-2021. Odds ratios were constructed using diagnostic history, age decile, study year and survival status. We used Generalized Linear Model (GLM) to predict the Decedent Observation Odds Ratio (DOOR) from study year, case observation odds ratio, age decile, non-covid conditions within counts of distinct covid-ever cases and their decedents. Odds ratios are relative to covid-never cases, or cases who didnot present with Covid-19 clinically. Results: High explanatory DOOR measures are observed for diagnostic codes commonly associated with inpatient Covid-19 mortality. High DOOR measures are also observed for individuals living with specific kinds of cancers, experiencing cardiac arrest or acute tubular necrosis. Conclusion: Covid-ever mortality is influenced by primary infection itself and exacerbations of pre-existing conditions. Consequences of primary infection are observable in GLM, as well as meaningful prior clinical risk factors such as cancer, diabetes, cardiac and respiratory disease. Long-covid conditions require surviving Covid-19 clinical presentation and are predictable from GLM models.

Publisher

Research Square Platform LLC

Reference35 articles.

1. The global impact of the coronavirus pandemic;Hiscott J;Cytokine Growth Factor Rev,2020

2. Epidemiology of CoViD-19 Pandemic: Recovery and mortality ratio around the globe;Noor AU;Pak J Med Sci,2020

3. Clarke KEN. Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2022 [cited 2023 Mar 7];71. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm

4. Ahmad FB. Provisional Mortality Data — United States, 2021. MMWR Morb Mortal Wkly Rep [Internet]. 2022 [cited 2023 Mar 7];71. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e1.htm

5. Akinbami LJ. SARS-CoV-2 Serology and Self-Reported Infection Among Adults — National Health and Nutrition Examination Survey, United States, August 2021–May 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2022 [cited 2023 Mar 7];71. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7148a4.htm

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3